Pregnancy


GUIDELINES - Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV- 1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States



Atazanavir (Reyataz) Use During Pregnancy  - 3/20/07

Is Antiretroviral Therapy during Pregnancy Associated with an Increased Risk of Preterm Delivery, Low Birth Weight or Stillbirth? - 4/18/06

Enrolling Women into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical Challenge - 2/28/06

Use of Infant-only Single-dose Nevirapine plus Zidovudine Reduces the Development of Nevirapine Resistance in Infants - 1/27/06

Longer Prophylaxis Is More Effective in Reducing HIV in the Placenta and Is Associated with Reduced HIV Transmission to Newborns - 12/05/05

Placental Transfer of Zidovudine in First Trimester of Pregnancy - 10/17/05

Antiretrovirals Improve Pregnancy Outcomes in HIV Positive Women - 4/06/05

Nevirapine Use for a Second Pregnancy Is Beneficial in Preventing Mother-to-Child Transmission of HIV, When Compared to a Transmission Rate of 25% Without Drug Use - 3/14/05

Updated Perinatal Guidelines from the National Institutes of Health - 2/25/05

Brief Antenatal HIV Treatment Tied to Emergence of Viral Drug Resistance - 2/14/05

European Research Group Recommends Offering Elective Caesarean Section Delivery to All HIV Positive Women, Even in Areas Where HAART Is Available - 2/04/05

Antenatal Counseling May Reduce HIV Transmission - 1/19/05